Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"It's business, nothing personal."
I'm sure Brad Pyatt is a great guy in his personal life, blah, blah, blah...He also happens to be the person who founded Hard Nutrition, which failed. He also happens to be running a business which has lost money four 4 consecutive years. It's called Musclepharm.
I don't take it kindly when people have my money by way of willful deception, which IMO, MP has achieved by their misleading, and some would say, if taken collectively, outright fraudulent press releases.
--medicare. Really.
--stock buyback program. Right.
--cash flow positive. Really.
--profitability. Fo' sure, Bro.
--millions in loan from billionaire. Fo fo mo sure, bro.
Blah blah blah.
"Annual numbers speak for themselves. $1M, $4M, $20M, $65M+. Any questions?"
No questions here. You've enlightened me with your investment insight. Revenue is the only metric that should be used when deciding which stock to purchase.
Just on the top of my head.
General Motors. Over $100 billion in revenue. Bankrupt. Government bailout. Common shareholders lost almost everything.
Chrysler. Over $50 billion in revenue. Bankrupt. Fiat bought them out. Common shareholders lost almost everything.
A123 Systems. $130 in revenue. Bankrupt. Common shareholders lost almost everything.
Solyndra. Over $100 million in revenue. Bankrupt. Common shareholders lost everything.
Fannie Mae, Freddie Mac, Goldman Sachs, BoA. Each had $500 billion in assets and over $100 billion in revenues. Bankrupt. Government bailouts.
If a product costs $5 to make and I sell it for $1, how much money do I make on each one? If I haven't grasped this concept after four years in business, what makes you think I will in the 5th year?
Anyone can issue a series of borderline fraudulent press releases to string along investors, take the money, lavish it on themselves and athletes, and put on a facet that they have a successful business when the opposite is true.
What MP has is a successful brand, not a sound business model. Kodak, Polaroid, Hostess, all had successful brands and hundreds of million in revenue but all went bankrupt.
As long as Musclehead Brad, Convicted Criminal Jeremy, Gangsta wanna-be Corey, and Mr. Bluher the Obfucator are at the helm, we can expect the same old, same old.
Sure we may see a spike in the share price due to irrational optimism. But then it's going come right back down to reflect the fundamentals of the company.
Have a healthy, happy and wealthy Holiday everyone.
I own LIWA, CXDC, CBP and CCL as my Chinese plays. They have the same story as NCTY: Amazing yoy and qoq growth, lots of cash on hand and selling at a steep discount to the market.
Unfortunately, at the moment they're out of favour because they're being stigmatized with the rest of the U.S. listed Chinese companies.
IMO, owning Chinese stocks now is akin to owning Internet stocks after the dotcom melt down of 2000. Some of those Internet stocks eventually recovered to become 50-300 baggers. If an investor picks the right Chinese stocks and is patient enough to wait it out, they can expect significant returns in the coming years.
The stock market goes in cycles. Unwavering patience is key with these Chinese plays.
GLTA.
"...and 1 person can write all those articles under a different name."
If that was the case then I'd assume that Musclepharm (a separate person under the law) or some other behind-the-scene pumper wrote the articles and had the writers disseminate them. Because I know for a fact that writers must use their real names on two of those websites. Also, Google does any accept articles written by an alias or anonymous pen in its news aggregator.
But whatever the case, keep the pump going. This has been dead money for far too long.
I can only see two alternatives at this point for current shareholders: Hope for a buyout or a pump and dump to get out.
Based on a four year abysmal record (4 years in business, 4 years of losses), anyone who thinks that Musclepharm will someday be a self-sustaining, profitable, and responsible company with current management in charge is delusional.
Have you ever heard of the "string theory" in physics? It's quite fascinating.
Have you ever heard of the "string along the suckers" theory in the stock market?
"Oh sugar daddy, Mr. Stock Market, I've changed my ways. It's gonna be different this time. I'm gonna be cash flow positive and things will change. Oh sugar daddy, I've seen the light and I'm gonna be making a profit to pay you back soon. Oh sugar daddy, I'm in rehab with Aegis and things are looking up. Oh sugar daddy, I've learned my lesson. I hooked up with this rich dude Mr. Frost and he's gonna help me out of this hole hole. Oh sugar daddy, it wasn't my fault. It was the meth producer's fault. But I'm getting the problem solved by bringing down his price. Just give me one more chance, sugar daddy. Please, sugar daddy. After all we've been through. Just one more hit, sugar daddy."
Regardless of how the details, favourable or unfavourable, were presented, the intended "net balance" of all those articles were the same: Musclepharm is an appealing investment with some risk involved. IF the company does this, IF the company does that (add your own IF string along items), there's a chance you could make 5-15 times your money (reader imagines slot machine sound: ka ching! ka ching! ka ching!).
Again, it's plausible, but highly unlikely, that a few articles would be written by unrelated third parties in a short period about the company that just happens to coincide with a pending dilution without a concerted effort behind them.
I could understand a single favourable article on MP written by a third party as coincidence. But more than one in a short period that just happens to coincide with an upcoming share offering? Common sense tells me it's a coordinated effort by those who have the most to gain.
IMO, the articles are now being written by third parties because in the past press releases by the company have been misleading and even borderline fraudulent. I've looked at many of the press releases in the past two years and taken collectively, a pattern IMO, of willful deception is evident--the intention of "stringing" along investors until the next quarter, the next quarter...
Since the articles are now written by third parties, the company is absolved of any legal wrongdoing.
Also, I'm not sure if I should be saddened or disgusted that they're now blaming the manufacturer for production cost issues. To me, it's just playing the blame game.
Please do a last successful p&d so I can bail the hell out.
"The bottom is the only thing I could hypothesize; that they have an ace hidden."
And their hole cards are A K off-suit and the community board is a rainbow 2 7 7 9 Q. It's a long shot but we still have a chance!
The COO, Mr. Bluher, is a trained lawyer.
Silence, delay, obfuscate. They're what lawyers do best.
"Those corporate muscles need to begin to stand out a lot better especially those CFP biceps."
LOL. "Five minute CFP workout" video on YouTube starring Musclehead Brad, Gangsta Wanna-be Cory and Mr. Bluher the Obfuscater.
I have never met the man. I evaluated his performance as the CEO of Musclepharm. My comments about him were from information available on MP's website and Google Finance.
I'm sure he's a good, decent person in his personal life.
Also, I strongly feel that what they've done was to "string" investors along with their b.s. announcements--to entice investors with false information while the stock plunged 99%. Each announcement taken individually would be hard to prove fraud. But taken collectively, a pattern of negligence and willful deception emerges. I wouldn't go as far as to call them scam artists or con artists or fraudsters but if this pattern of obfuscation and deception continues...
Holding out for a possible buy out announcement or possible pump and dump so I can bail the hell out. My average cost is $5.95, so I may even make a profit if there's a pump in the near future.
If there's a coordinated pump, it will be the best dump I've taken in a long time.
Brad Pyatt. He didn't last too long in the NFL. Doesn't look like he'll last long as a CEO, either.
Instead of paying yourself $400,000 or $500,000 a year, pay yourself $150,000 a year. Then hire a supply chain management specialist and a good accountant and pay them $200,000 each a year. And take their advice.
Oh I forgot. Brad Pyatt already knows everything. There's nothing anyone can teach him. Musclehead.
I had several impressions of the company from the dribs and drabs they had disseminated:
--they were going to be cash flow positive and that would turn the company around.
--they were going to be profitable and that would turn the company company.
--their rapid revenue increase was going to narrow their losses. According to the theory of economy of scale the cost per unit goes down as production ramps up. I guess economy of scale doesn't apply to Musclepharm because they're special(insert laughter here).
--the 8% of the company they paid to the consultants would turn things around.
--Mr. Frost, worth $2.4 billion, was going to lend them $20 million and that would help turn things around.
Now, the amendments to the SEC filing and pending dilution. I can't take this incessant muscleturd b.s. anymore.
MP Management. We obfuscate because we no idea how to run a business.
Get your MP shares now before it's too late! Need to pay off that mortgage? Car loan dragging you down? Want that around-the-world cruise? Kids need college tuition?
Buy, buy, buy MP shares now!
We're not supposed to talk about other stocks on this board. But I'll give you a hint: The world's highest paid golfer of 2012 signed a 5 year tiger of a deal with the company last year. The company's logo is on his golf bag.
"Go back to pumping your other crappy stock with its stupid topical gel."
Please stick to the facts when arguing. I happen to be up about 80% on that stupid topical gel company. Musclepharm's stock is down 99%. That stupid topical gel company has tier 1 athletes as its endorsers while MP has tier 3 athletes.
Your tone and insistence that we only post glowing reviews of the musclehead executives makes me wonder if you're not a tool for the muscleturds.
Being a shareholder should not preclude me from critiquing the company if there are glaring deficiencies that management has refused to address, sheriff.
I love Muscle pharm. There's enormous potential in the company.
yoy quarter growth: $3 mil. --> $18 mil.
qoq growth: $15 mil. --> $18 mil.
Market cap. of only $12 million. Get in now before it's too late!
We have a new sheriff in town: drive929.
Looks like the Musclehead executives are preparing a pump and dump for the next round of dilution. Everyone please be on your best behavior. Maybe we can bail out.
It's time to change my tone of the company and help potential investors to get in on the ground floor of this once in a life time opportunity that is Musclepharm!
I'm a shareholder.
You want something new? Then let's see something new with this company. Like concrete changes that'll add value to investors who GAVE this company money.
It's the same old, same old with this company. Four years running now from what I understand. What's new to post? This thing's a running joke.
I suggest that some of you stop drinking the kool-aid. It's hard to argue with a four year track record.
Prove to the shareholders that we're wrong and do something new.
Again, if a product costs $1.20 and sells for $1, the more you sell of it the more you lose. Simple concept.
Massive losses on current product line. Four years running now.
Start Fitmiss line without addressing COGS problems with previous line. Expected result? Massive losses.
Third product line targets senior citizens. Each product includes a free set of dentures. And if you buy 3 in month (proof of purchase required) you get a free cane with an MP logo on it.
I know the senior citizen supplement line's gonna be the bomb because this guy and his friends are going form to a line blocks long to bust in on release date.
http://flowtv.org/wp-content/uploads/2009/09/granpa.png
4 out of the top 5. Not bad.
I thought the industry would consolidate first before running again. CSIQ's been on a tear.
Looks like the solar panel industry is on the rebound without consolidation first.
You wrote, "But, remember unless you sell, you have gained nothing." You are absolutely right. I couldn't agree with you more. It's just a matter of WHEN. I'm already up about 80% and haven't sold a share.
I'm not concerned about the stock's daily fluctuations. Right, now I'm mainly concerned about two things:
--the progress of the ongoing clinical trials.
--if management is pushing hard on getting the Drops in 7-11 and other convenience stores.
The stock price will ALWAYS decrease or increase to reflect the fundamentals of a company. As long as the Fuse's fundamentals are improving, Fuse's stock price will increase to reflect them.
I used to trade stocks, the in-and-out business (premature pull out syndrome). There was just too much stress involved--having to always second guess myself and wasn't worth it. IMO, the most useful tool of a trader is the ability to estimate the consolidation price, which is perfect for estimating the entry point.
You can make a lot of money being a trader, just as you can an investor, or both. It just depends on how much stress one can tolerate.
Warren Buffett wrote that when you invest in a company you're investing in its people. I've looked at the credentials and accomplishments of Fuse's executive team, and between them and the tag team of bgrass1 and VVVVVV, my bet is on Fuse.
Having said that, MP's 2.6 million float is so tight that the stock will soar on a barrage of positive news.
Forget the stock market for a moment.
If I own a business, in part or in whole, how do I make money? Only when the company makes money. If the company doesn't make money, I don't make money. If the company loses money, I lose money.
If a product costs $1.2 to make and sells for $1.00, the more I sell of it the more I lose. Therefore, I don't want to sell more until I either reduce the production cost or increase the selling price.
If I've been in business for four years and have lost money all four years, the chances of me succeeding the fifth year are slim to none.
Even this guy understands these simple concepts:
http://www.fondsdecranhd.com/walls/homer_simpson_superman_2_other.jpg
What if in the midst of all this uncertainty and frustration for many, MSLP plays out like Dex One? A company left for dead until big money lined up behind it. Shares are up over 100% in about two weeks. Just keeping the options open.
Better call Saul if MP is causing you unnecessary pain and suffering!
http://www.bettercallsaul.com
If you want to do this smack-down style: You will be right in the short-term with your 10-50% gains, in-and-out (pay the difference between the ask and bid, higher taxes, more commission, too). I will be right with my 10-20 bagger in the long-term, stress free.
And anyone who both trades and invests in Fuse will be right both ways.
Be careful not to overindulge. Caffeine is a diuretic and too much of it can flush essential nutrients out the body via urine.
Dude, I'm more wrong than right but I get the impression that some people engage in extreme thinking, which is really unhealthy and unproductive, especially in picking stocks. A good stock picker needs to have the skill sets of a trader and an investor. Drop is a stock that you can both invest AND trade in at the same time. It's not one or the other.
For example, we'll use nice rounded numbers, you can hold 100,000 shares for the long-term (2-3 years) and play it from these angles:
--let the EnerJel business grow.
--wait until the Drops are in mainstream distribution.
--wait for Fuse to use its star athletes to promote their products more.
--there are ongoing clinical trials of its Drop technology. Remember those?
At the same time you can also trade 20,000 shares (more or less depending on your penchant for risk). This will allow you to take advantage of the price swings.
When or IF Fuse announces a pharma deal, you can throw the support level, resistance point, Golden Cross, and other technical theories out the window!
A company is only as good as the people running it. Based on the education, experience and track record of Fuse's management, do you believe they will succeed? No reason not to think so.
When someone scores their first 10 or 20 bagger, they will understand the adage, "Patience is a virtue."
GLTA.
We'll tell everyone 5hr Energy is for losers, while we secretly admire its business model and try to duplicate it.
bgrass1 wrote, "P.S. Why do you think they have not announced any additional outlets for EJ?"
Fuse news release minutes before: "...is pleased to announce today that it has commenced overseas sales of its EnerJel(TM) brand product through non-exclusive international distribution partnerships in both South America and Europe..."
I'm guessing that you're frustrated (maybe disgruntled?) because your entry point could have been better. If it was, let's say $.12, you'd be in a better mood and not constantly bashing the company?
Thanks for the chuckle, bgrass1.
Fingers crossed for positive clinical trials in the next 4-6 months.
Remember, the greatest stock picker of all time, Warren Buffett, is an investor and not a trader.
The stock price will ALWAYS reflect the fundamentals of a company.
Let me ask you something. Would you rather have 1% of a billion or 100% of a million?
As an investor, dilution of common shares is beneficial because it keeps the company out of debt. Fuse is essentially debt free.
Second, dilution can either increase or decrease shareholder value depending on how effectively management uses the money. If they use it to pay themselves extravagant salaries and bonuses, which many pinkies do, then dilution is definitely detrimental to shareholders. On the other hand, if the money was wisely used to create, manufacture products/services and other activities that grow the company, then the eventual stock price increase will more than offset the increase in the number of shares.
It all depends on how management uses the money.
A trader's view of dilution may be: More shares, pps goes down.
An investor's view of dilution: Use the money to build the business, pps will eventually reflect the fundamentals of the company.
Applied to Fuse, a trader's line of thinking may be:
--what's the next support level? How's the volume?
--will we be trading above or below the 200 MA the next few weeks?
--Golden Cross or Death Cross, etc..
An investor's:
--how are the clinical trials coming along?
--why isn't Tiger promoting the Drops more?
--are they working on placing the products at point of sales?
--have their margins improved, sales increased, etc...
It's good to have both perspectives. A company is only as good as the people running it. Dilution can be a friend or foe, depending on how effectively management uses the money.
Would you rather have 1% of a billion or 100% of a million?